Organic Letters
Letter
desired nitriles 2b−2i in moderate to excellent yields (Section
A). The electron-donating or -withdrawing nature of
substituent has little impact on the reactivity. The bromo or
chloro substituents on the phenyl ring remain inert. Both cyclic
and acyclic alkyl units at the α-position of the halides were
tolerated, resulting in 64−94% yields of 2j−2q. Tertiary
bromide 1r derived from 2-methyl-1-indanone was smoothly
transformed into the nitrile with 94% yield under standard
conditions. The remarkable versatility of this approach was
further demonstrated by reductive cyanation of α-bromo
phenol esters 3 (Section B) and α-bromo carboxamides 5
(Section C). Isobutyrates of phenol, nathpanol, benzyl alcohol,
and allylic alcohol 3a−3n were converted to the corresponding
nitriles 4a−4n in reasonable to excellent yields. Among these
cases, bromo or iodo substituents on the aryl ring (4e, 4g, 4h,
4l) and C=C bond of cinnamyl group (4n) were preserved.
For carboxylic ester of p-cresol with longer aliphatic chain (3o-
3s) or cyclic substituent (3t−3v), the protocol also achieved
good cyanation yields in most of the cases. In some cases, using
N-cyano-N-phenylbenzenesulfonamide (NCPs) instead of
NCTs facilitated the isolation of cyanation products (4b−4h,
4j−4n). By using MPMN instead of NCTs, α-bromo N-aryl or
N-alkyl isobutyramides as well as cyclobutanecarboxylic amide
smoothly underwent reductive cyanation, resulting in the
products 6a−6o with high yields in most of the scenarios. The
molecular structure of 6a was identified by X-ray crystallog-
raphy. Thanks to the noble-metal-free and neutral conditions,
boronic acid pinacol ester group (Bpin), methyl sulfide group,
dimethylamino group, and piperonyl group did not impose
negative impact on this reductive cyanation (6j, 6k, 6m, and
6n). The merit demonstrated by 6j is beneficial to further
transformation with the miscellaneous tools of transition-
metal-catalyzed cross coupling. More impressively, this
protocol can be applied to introducing nitrile group and
quaternary carbon center into β-lactams at the same time by
employing α-halo-β-lactams as the substrates (6p and 6q).
Notably, α,α-difluorinated α-bromo acetate amide can also be
cyanated (6r) in acceptable yield, along with unwanted
reductive debromination of 5r. The above-mentioned results
of products 4q−4v and 6o demonstrated an practical
alternative of avoiding the selectivity obstacle in the
preparation of α,α-disubstituted β-amino amides via the
dialkylation or cycloalkylation of cyanoacetate with two
different alkyl halides or terminal dihalogenated alkanes.25
Encouraged by these results, we further demonstrated the
benefits of this synthetic tool from the following aspects: (i)
varied transformation of cyanation products (Scheme 2); (ii)
the late-stage functionalization of pharmaceuticals and
bioactive molecules (Scheme 3); (iii) gram-scale synthesis
(Scheme 4). The synthetic utility of this reductive cyanation
was projected on the diverse transformation of products. A
variety of transformations from nitriles to molecules, including
3-amino alcohol, 1,3-diamines with two primary amine
moieties with different N-protecting groups, α,α-disubstituted
malonamide with different N-terminus, and β-hydroxy26 or
-amino amide, were accomplished in moderate to high yields
(Scheme 2). Late-stage functionalization represents an
opportunity to expand the toolbox in hands of medicinal
chemists and in turn increase the chemical space explored in
drug discovery efforts.27 Because of the facile accessibility of α-
ketone substituted tertiary alkyl bromides by brominating the
corresponding ketone with hydrogen bromide, we achieved the
cyanative modification of acetylcholinesterase inhibitor Done-
Scheme 2. Transformation of α-Cyanocarbonyls Reaction
Conditions
1
1
(a) 2a (0.5 mmol, 1.0 equiv), CoCl2 (1.5 mmol, 3.0 equiv), (Boc)2O
(3.0 mmol, 6.0 equiv), NaBH4 (5.0 mmol, 10.0 equiv), MeOH (5
mL), 0 °C, overnight. (b) 2a (0.5 mmol, 1.0 equiv), BnNH2 (0.6
mmol, 1.2 equiv), Ti(OEt)4 (2 mL), 85 °C, 6 h; then with the
conditions of panel (a). (c) 6a (0.5 mmol, 1.0 equiv), LiAlH4 (2.5
mmol, 5.0 equiv), 80 °C, overnight. (d) 6a (0.5 mmol, 1.0 equiv),
K2CO3 (1.0 mmol, 2.0 equiv), 30 wt % H2O2 solution (2.5 mmol, 5.0
equiv), DMSO (2 mL), rt, 20 h. (e) 6a (0.5 mmol, 1.0 equiv) with the
conditions of (a). (f) 2a, with the method reported in ref 26.
Scheme 3. Late-Stage Modification of Pharmaceuticals
Scheme 4. Gram-Scale Synthesis
pezil (8a) by transforming Donepezil to its tertiary alkyl
bromide derivative and then implanting nitrile group with this
method (Scheme 3). Anesthetic Propofol, antihistamine drug
Desloratadine, antidepressant Fluoxetine, steroid Estrone, and
quetiapine’s active metabolite norquetiapine were converted to
the corresponding α-bromo esters or amides, and after
applying this cyanation method, products 8b−8f were
delivered in reasonable to high yields. The 2,2-dimethyl
cyanoacetyl group can be installed as a degradation-resistant
“tether” into these pharmaceuticals through this process. By
further transformation of implanted nitrile group to amino
group, these pharmaceuticals could be affixed to bioactive
peptides or proteins, providing potent option to explore the
vast potential of well-established drugs. Larger-scale reaction of
tertiary alkyl bromides with NCTs or MPMN and zinc dust
was performed. The corresponding α-cyano molecules were
produced gram-scale in 89−91% yields without any
modification of the optimized conditions (Scheme 4).
To validate the reaction pathway, a couple of control
experiments were designed and conducted (Scheme 5). No
2529
Org. Lett. 2021, 23, 2527−2532